Development of a human placental extract for the prevention of necrotizing enterocolitis in premature babies

Active Project Grant Awarded Last action

Award ID
R44HD100243
Recipient
Awarding agency
Obligated
$9,214,792

Award facts

Assistance listing
93.865 Child Health and Human Development Extramural Research
Completion date 91% complete
Originally
Funding
  • $8,444,809.00 Federal
  • $769,983.00 Non-federal
Place of performance
Winston-Salem, NC 27103, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $826,522 $0
Amendment IND enabling studies and manufacturing scale up of human placental extract to prevent surgical necrotizing enterocolitis $976,322 $0
Amendment $0 $0
Amendment $0 $0
Amendment IND enabling studies and manufacturing scale up of human placental extract to prevent surgical necrotizing enterocolitis $1,121,897 $0
Amendment $1,121,897 $0
Amendment $1,121,897 $0
Amendment $0 $0
Amendment IND enabling studies and manufacturing scale up of human placental extract to prevent surgical necrotizing enterocolitis $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $755,655 $0
Amendment $755,655 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $769,983 $0
Amendment $769,983 $769,983
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $112,498 $0
Original award $112,500 $0
Show all 27

Quick answers

Who received award R44HD100243?

R44HD100243 was awarded to Plakous Therapeutics, Inc. by National Institute of Child Health and Human Development (National Institutes of Health) on July 2, 2020.

How much is award R44HD100243 worth?

$9,214,792 has been obligated on R44HD100243: $8,444,809 in federal funding and $769,983 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login